Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Defensive Intrval Ratio

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Days.

The item "Defensive-Intrval-Ratio" stands at 287.72 days as of 09/30/2025.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Defensive Intrval Ratio" stands at 287.72 Days. This represents an increase of 22.80 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -18.56 percent compared to the value the year prior.
The 1 year change in percent is -18.56.
The 3 year change in percent is -33.08.

The Serie's long term average value is 318.02 days. It's latest available value, on 09/30/2025, is 9.53 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is +22.80%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -36.35%.

Defensive Intrval Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Defensive Intrval Ratio905,699,262,464.00
LogoJohnson & Johnson - Defensive Intrval Ratio486,508,953,600.00
LogoAbbVie Inc - Defensive Intrval Ratio399,570,305,024.00
LogoRoche Holding AG - Defensive Intrval Ratio317,433,206,677.55
LogoAstraZeneca PLC - Defensive Intrval Ratio280,205,508,085.11